1.Postirradiation Changes of White Blood Cellsand Lymphocyte Subpopulations in Cancer Patients.
Woong Ki CHUNG ; Byung Sik NAH ; Taek Keun NAM ; Young Hee NOH ; Sung Ja AHN
Journal of the Korean Society for Therapeutic Radiology 1996;14(1):53-60
PURPOSE: Radiation-induced alteration in the immune function is well known phenomenon in cancer patients. Our purpose is to evaluate the extent of immune suppression immediately after mediastinal or pelvic irradiation, which include significant volume of active bone marrow in adults. METHODS AND MATERIALS: 48 cancer patients with mediastinal(N=29) and pelvic irradiation(N=19) were the basis of this analysis. Age ranged from 36 to 76 and mean and median value was 57 years, respectively. Sex ratio was 1.3(M:F = 27/21). The immunological parameters were the complete blood cell(CBC) with differenial cell(D/C) count, T cel subset(CD3, CD4, CD8, CD19), NK cell test(CD16,CD56), and serum immunoglobulin (lgG,lgA,lgM) level. RESULTS: The mean value of white blood cell(WBC) was reduced from 7017 to 4470 after irradiation (p=0.0000). In the differential count, the number of lymphocyte, neutrophil, and basophil was markedly reduced with statistical significance(p<0.01) and the number of monocyte was not changed and, on the contrary, that of eosinophil was increased by irradiation.In the lymphocyte subpopulation analysis, the number of all subpopulations, CD3(T cell), CD4(helper T cell), CD8(suppressor T cell), CD16(NK cell), CD19(B cell) was reduced with statistical significance. The mean ratio of CD4 to CD8 in all patients was 1.09 initially and reduced to 0.99 after radiotherapy(p = 0.34), but the proportional percentage of all subpopulations was not changed except CD19(B cell) after irradiation.In the immunoglobulin study, initial values of lg G, lg A, and lg M were relatively above the normal range and the only lg M was statistically significantly reduced after radiotherapy(p=0.02) CONCLUSION: Mediastinal and pelvic irradiation resulted in remarkable suppression of lymphocyte count in contrast to the relatively good preservation of other components of white blood cells. But the further study on the functional changes of lymphocyte after radiotherapy may be necessary to conclude the effects of the radiation on the immunity of the cancer patients.
Adult
;
Basophils
;
Bone Marrow
;
Eosinophils
;
Humans
;
Immunoglobulins
;
Killer Cells, Natural
;
Leukocytes
;
Lymphocyte Count
;
Lymphocyte Subsets*
;
Lymphocytes*
;
Monocytes
;
Neutrophils
;
Radiotherapy
;
Reference Values
;
Sex Ratio
2.Determination of Cyanogenic Compounds in Edible Plants by Ion Chromatography.
Hye Jeon CHO ; Byung Kyung DO ; Soon Mi SHIM ; Hoonjeong KWON ; Dong Ha LEE ; Ahn Hee NAH ; Youn Ju CHOI ; Sook Yeon LEE
Toxicological Research 2013;29(2):143-147
Cyanogenic glycosides are HCN-producing phytotoxins; HCN is a powerful and a rapidly acting poison. It is not difficult to find plants containing these compounds in the food supply and/or in medicinal herb collections. The objective of this study was to investigate the distribution of total cyanide in nine genera (Dolichos, Ginkgo, Hordeum, Linum, Phaseolus, Prunus, Phyllostachys, Phytolacca, and Portulaca) of edible plants and the effect of the processing on cyanide concentration. Total cyanide content was measured by ion chromatography following acid hydrolysis and distillation. Kernels of Prunus genus are used medicinally, but they possess the highest level of total cyanide of up to 2259.81 CN-/g dry weight. Trace amounts of cyanogenic compounds were detected in foodstuffs such as mungbeans and bamboo shoots. Currently, except for the WHO guideline for cassava, there is no global standard for the allowed amount of cyanogenic compounds in foodstuffs. However, our data emphasize the need for the guidelines if plants containing cyanogenic glycosidesare to be developed as dietary supplements.
Chromatography
;
Dietary Supplements
;
Distillation
;
Flax
;
Food Supply
;
Ginkgo biloba
;
Glycosides
;
Hordeum
;
Hydrolysis
;
Manihot
;
Phaseolus
;
Phytolacca
;
Plants, Edible
;
Plants, Medicinal
;
Prunus
3.An Analysis on Factors Affecting Local Control and Survival in Nasopharyngeal Carcinoma.
Woong Ki CHUNG ; Jae Shik CHO ; Seung Jin PARK ; Jae Hong LEE ; Sung Ja AHN ; Taek Keun NAM ; Chan CHOI ; Young Hee NOH ; Byung Sik NAH
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1999;17(2):91-99
PURPOSE: This study was performed to find out the prognostic factors affecting local control, survival and disease free survival rate in nasopharyngeal carcinomas treated with chemotherapy and radiation therapy. MATERIALS AND METHODS: We analysed 47 patients of nasopharyngeal carcinomas, histologically confirmed and treated at Chonnam University Hospital between July 1986 and June 1996, retrospectively. Range of patients' age were from 16 to 80 years (median; 52 years). Thirty three (70%) patients was male. Histological types were composed of 3 (6%) keratinizing, 30 (64%) nonkeratinizing squamous cell carcinoma and 13 (28%) undifferentiated carcinoma. Histological type was not known in 1 patient (2%). We restaged according to the staging system of 1997 American Joint Committee on Cancer. Forty seven patients were recorded as follows: T1; 11 (23%), T2a; 6 (13%), T2b; 9 (19%), T3; 7 (15%), T4; 14 (30%), and N0; 7 (15%), N1; 14 (30%), N2; 21 (45%), N3; 5 (10%). Clinical staging was grouped as follows: Stage I; 2 (4%), IIA; 2 (4%), IIB; 10 (21%), III; 14 (30%), IVA; 14 (30%) and IVB; 5 (11%). Radiation therapy was done using 6 MV and 10 MV X- ray of linear accelerator. Electron beam was used for the lymph nodes of posterior neck after 4500 cGy. The range of total radiation dose delivered to the primary tumor was from 6120 to 7920 cGy (median; 7020 cGy). Neoadjuvant chemotherapy was performed with cisplatin+5-fluorouracil (25 patients) or cisplatin+pepleomycin (17 patients) with one to three cycles. Five patients did not received chemotherapy. Local control rate, survival and disease free survival rate were calculated by Kaplan-Meier method. Generalized Wilcoxon test was used to evaluate the difference of survival rates between groups. Multivariate analysis using Cox proportional hazard model was done for finding prognostic factors. RESULTS: Local control rate was 81% in 5 year. Five year survival rate was 60% (median survival; 106 months). We included age, sex, cranial nerve deficit, histologic type, stage group, chemotherapy, elapsed days between chemotherapy and radiotherapy, total radiation dose, period of radiotherapy as potential prognostic factors in multivariate analysis. As a result, cranial nerve deficit (P=0.004) had statistical significance in local control rate. Stage group and total radiation dose were significant prognostic factors in survival (P=0.006, P=0.012), and in disease free survival rates (P=0.003, P=0.008), respectively. Common complications were xerostomia, tooth and ear problems. Hypothyroidism was developed in 2 patients. CONCLUSION: In our study, cranial nerve deficit was a significant prognostic factor in local control rate, and stage group and total radiation dose were significant factors in both survival and disease free survival of nasopharyngeal carcinoma. We have concluded that chemotherapy and radiotherapy used in our patients were effective without any serious complication.
Carcinoma
;
Carcinoma, Squamous Cell
;
Cranial Nerves
;
Disease-Free Survival
;
Drug Therapy
;
Ear
;
Humans
;
Hypothyroidism
;
Jeollanam-do
;
Joints
;
Lymph Nodes
;
Male
;
Multivariate Analysis
;
Neck
;
Particle Accelerators
;
Proportional Hazards Models
;
Radiotherapy
;
Retrospective Studies
;
Survival Rate
;
Tooth
;
Xerostomia
4.MDM2, p53 and pRb Expression Prior to Definitive Chemoradiotherapy in Esophageal Carcinoma.
Mee Sun YOON ; Taek Keun NAM ; Jae Hyuk LEE ; Sang Hee CHO ; Ju Young SONG ; Sung Ja AHN ; Ik Joo CHUNG ; Woong Ki CHUNG ; Byung Sik NAH
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2007;25(4):193-200
PURPOSE: This study evaluated the pretreatment expression patterns of MDM2, p53, and pRb proteins to determine if the expression patterns could predict the outcome of concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma and aid in the decisions for the selection of treatment modalities. MATERIALS AND METHODS: Fifty-one patients that were treated with definitive chemoradiotherapy for stage I~IVa esophageal squamous cell carcinoma were selected for this study. Radiotherapy was administered with daily 1.8~2 Gy fractions up to a median dose of 54 Gy for primary tumors, and with four cycles of cisplatin/5- fluorouracil chemotherapy that was administered every 4 weeks, the first two cycles of which were administered concurrently with radiotherapy. Expression of MDM2, p53, and pRb was investigated by immunohistochemical analysis using pretreatment biopsy specimens. RESULTS: MDM2, p53, and pRb were detected with high immunoreactivity in 19.6%, 27.5%, and 66.7% of the patients, respectively. However, there was no significant correlation between expression of these factors and clinical outcome. By the use of multivariate analysis with nine covariates-age, tumor location, tumor length, stage, pathological response, clinical response, MDM2 expression, p53 expression, and pRb expression, only pathological response and stage were significant factors for cause-specific survival. CONCLUSION: Expression of MDM2, p53, and pRb was not found to be clinically significant for predicting outcomes after CCRT in this study. Further studies with a larger patient population and longer follow-up periods are needed to re-evaluate the expression pattern and to identify new predictors for CCRT response.
Biopsy
;
Carcinoma, Squamous Cell
;
Chemoradiotherapy*
;
Drug Therapy
;
Esophageal Neoplasms
;
Fluorouracil
;
Follow-Up Studies
;
Humans
;
Immunohistochemistry
;
Multivariate Analysis
;
Radiotherapy
5.Inhibitory Effects of Ginsenoside Metabolites, Compound K and Protopanaxatriol, on GABAC Receptor-Mediated Ion Currents.
Byung Hwan LEE ; Sung Hee HWANG ; Sun Hye CHOI ; Hyeon Joong KIM ; Joon Hee LEE ; Sang Mok LEE ; Yun Gyong AHN ; Seung Yeol NAH
The Korean Journal of Physiology and Pharmacology 2013;17(2):127-132
Ginsenosides, one of the active ingredients of Panax ginseng, show various pharmacological and physiological effects, and they are converted into compound K (CK) or protopanaxatriol (M4) by intestinal microorganisms. CK is a metabolite derived from protopanaxadiol (PD) ginsenosides, whereas M4 is a metabolite derived from protopanaxatriol (PT) ginsenosides. The gamma-aminobutyric acid receptorC (GABAC) is primarily expressed in retinal bipolar cells and several regions of the brain. However, little is known of the effects of ginsenoside metabolites on GABAC receptor channel activity. In the present study, we examined the effects of CK and M4 on the activity of human recombinant GABAC receptor (rho1) channels expressed in Xenopus oocytes by using a 2-electrode voltage clamp technique. In oocytes expressing GABAC receptor cRNA, we found that CK or M4 alone had no effect in oocytes. However, co-application of either CK or M4 with GABA inhibited the GABA-induced inward peak current (IGABA). Interestingly, pre-application of M4 inhibited IGABA more potently than CK in a dose-dependent and reversible manner. The half-inhibitory concentration (IC50) values of CK and M4 were 52.1+/-2.3 and 45.7+/-3.9 microM, respectively. Inhibition of IGABA by CK and M4 was voltage-independent and non-competitive. This study implies that ginsenoside metabolites may regulate GABAC receptor channel activity in the brain, including in the eyes.
Brain
;
Eye
;
gamma-Aminobutyric Acid
;
Ginsenosides
;
Humans
;
Oocytes
;
Panax
;
Retinal Bipolar Cells
;
RNA, Complementary
;
Sapogenins
;
Xenopus
6.VEGF as a Predictor for Response to Definitive Chemoradiotherapy and COX-2 as a Prognosticator for Survival in Esophageal Squamous Cell Carcinoma.
Mee Sun YOON ; Taek Keun NAM ; Ji Shin LEE ; Sang Hee CHO ; Ju Young SONG ; Sung Ja AHN ; Ik Joo CHUNG ; Jae Uk JEONG ; Woong Ki CHUNG ; Byung Sik NAH
Journal of Korean Medical Science 2011;26(4):513-520
We investigated the patterns of pretreatment expression of the epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) by immunohistochemical staining and determined their correlation with treatment response and survival in 44 patients with esophageal squamous cell carcinoma (ESCC) treated with definitive concurrent chemoradiotherapy (CCRT). The definitive CCRT consisted of a median dose of 54 Gy (range: 40.0-68.4 Gy) and two cycles of concurrent administration of mostly 5-fluorouracil + cisplatinum. High expression of EGFR, VEGF, and COX-2 was found in 79.5%, 31.8%, and 38.6%, respectively. The Cox regression analysis for overall survival (OS) showed that both the treatment response and COX-2 expression were significant. The 3-yr OS rates of patients that achieved a complete response and those that did not were 46.7% and 5.3%, respectively (P = 0.006). The logistic regression analysis for treatment response with various parameters showed that only a high expression of VEGF was significantly associated with a complete response. Unlike other well-known studies, higher expression of VEGF was significantly correlated with a complete response to CCRT in this study. However, higher expression of COX-2 was significantly associated with shorter survival. These results suggest that VEGF might be a predictive factor for treatment response and COX-2 a prognostic factor for OS in patients with ESCC after definitive CCRT.
Aged
;
Antineoplastic Agents/therapeutic use
;
Carcinoma, Squamous Cell/drug therapy/*mortality/radiotherapy/*therapy
;
Cisplatin/therapeutic use
;
Combined Modality Therapy
;
Cyclooxygenase 2/*metabolism
;
Drug Therapy, Combination
;
Esophageal Neoplasms/drug therapy/*mortality/radiotherapy/*therapy
;
Female
;
Fluorouracil/therapeutic use
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Predictive Value of Tests
;
Radiation Dosage
;
Receptor, Epidermal Growth Factor/metabolism
;
Regression Analysis
;
Survival Rate
;
Vascular Endothelial Growth Factor A/*metabolism
7.Rupture of a Bleeding Pancreatic Pseudocyst into the Stomach: a Case Report.
Young Don KIM ; Byung Kyu NAH ; Jung Won HWANG ; Hyun Il HONG ; Sung Kyu YOON ; Koon Hee HAN ; Hye Young CHOI ; Kwang Seok KIM ; Jae Hong AHN ; Gab Jin CHEON
Korean Journal of Gastrointestinal Endoscopy 2005;31(4):273-277
Pancreatic pseudocyst is a well-known complication of pancreatitis. However spontaneous perforation and/or fistularization is rare. Perforations into the free peritoneal cavity, stomach, duodenum, colon, portal vein, pleural cavity, and through the abdominal wall have been reported. Rupture of pseudoaneurysm or bleeding pseudocyst following pancreatitis is a severe complication that can lead to massive gastrointestinal bleeding. Especially, rupture of a bleeding pseudocyst into the stomach combined with splenic artery pesudoaneurysm is very rare. We experienced a case of massive bleeding from pancreatic pseudocyst with pseudoaneurysmal rupture into the stomach which was controlled nonoperatively by splenic artery coil embolization and conservative treatment. We report the case with the literatures review.
Abdominal Wall
;
Aneurysm, False
;
Colon
;
Duodenum
;
Embolization, Therapeutic
;
Hemorrhage*
;
Pancreatic Pseudocyst*
;
Pancreatitis
;
Peritoneal Cavity
;
Pleural Cavity
;
Portal Vein
;
Rupture*
;
Splenic Artery
;
Stomach*
8.Induction of Anti-tumor Immunity by Vaccination with E7 of HPV16 and IL-12.
Eun Kyung PARK ; Tae Young JIN ; Chul Gu YOON ; Mi Nah CHOI ; Seung Won HUH ; Su Mi BAE ; Young Wan KIM ; Joo Hee YOON ; Woong Shick AHN ; Chong Kook KIM ; Jun Mo LEE ; Sung Eun NAMKOONG ; Kim Dou KANG
Korean Journal of Obstetrics and Gynecology 2003;46(12):2373-2379
OBJECTIVE: Interleukin-12 is well known to induce cellular immune response materials and suppress the tumor growth. HPV infection has significant roles in cervical carcinogenesis, and HPV oncoprotein E6 and E7 are important roles in formation and maintenance of cervical cancer. E7 specific immune response was detected in cervical cancer patients, and this shows that E7 protein would be important in potential immunetherapy in cervical cancer. This study is aimed to investigate antitumor effect and E7 immune response by injection of adenovirus IL-12 and E7 in cervical cancer animal model. METHODS: In the cervical cancer animal model using C57BL/6 mice and HPV16 E7 immortalized hosts, 5 X 10(8) pfu/100 ul of PBS, AdLacZ, AdE7 and AdIL-12 were injected into the tumor mass when the tumor sized is increased to 7-8 mm. After the injection, the tumor size was caliperated every 2-3 days, and pathologic and blood studies were done on day 1, 3, 5, 7, 11, 12, and 21 days. The expression level of IL-12 and INF- and E7 specific immune response were measured by ELISA. RESULTS: After the injection of AdIL-12 into the tumor mass, 45% of tumor growth suppression was noted in comparison with control group. In the cases of combination injections of AdIL-12 and AdE7, 80% growth suppression was observed, and complete regression was shown in 40% of the study group. After injection of AdIL-12, the expression of IL-12 in the tumor mass was 9 time higher than that of control group, and 6 times higher in blood sample in comparison with control group. In the group with combined AdIL-12 and AdE7, the highest expression of INF- was noted in comparison with single injection of AdIL-12 or control group. IgGI and IgG2b isotype expression level increased 2.5 times and 2.2 times respectively 3 weeks after adenovirus injection. CONCLUSION: In cervical cancer animal model, IL-12 and E7 application using Adenovirus vector is significant antitumor effect and this demonstrates the potential immunotherapy in near future.
Adenoviridae
;
Animals
;
Carcinogenesis
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunity, Cellular
;
Immunoglobulin G
;
Immunotherapy
;
Interleukin-12*
;
Mice
;
Models, Animal
;
Uterine Cervical Neoplasms
;
Vaccination*
9.A Retrospective Study of the Radiotherapy Care Patterns for Patients with Laryngeal Cancer and Comparison of Different Korean Hospitals Treated from 1998 through 1999.
Woong Ki CHUNG ; Il Han KIM ; Mee Sun YOON ; Sung Ja AHN ; Taek Keun NAM ; Ju Young SONG ; Jae Uk CHUNG ; Byung Sik NAH ; Joon Kyoo LEE ; Hong Gyun WU ; Chang Geol LEE ; Sang Wook LEE ; Won PARK ; Yong Chan AHN ; Ki Moon KANG ; Jung Soo KIM ; Yoon Kyeong OH ; Moon June CHO ; Woo Yoon PARK ; Jin Hee KIM ; Doo Ho CHOI ; Hyong Geun YUN ; Woo Cheol KIM ; Dae Sik YANG ; Seung Chang SOHN ; Hyun Suk SUH ; Ki Jung AHN ; Mison CHUN ; Kyu Chan LEE ; Young Min CHOI ; Tae Sik JEUNG ; Jin Oh KANG
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2009;27(4):201-209
PURPOSE: To investigate the care patterns for radiation therapy and to determine inter-hospital differences for patients with laryngeal carcinoma in Korea. MATERIALS AND METHODS: A total of 237 cases of laryngeal carcinoma (glottis, 144; supraglottis, 93) assembled from 23 hospitals, who underwent irradiation in the year of 1998 and 1999, were retrospectively analyzed to investigate inter-hospital differences with respect to radiotherapy treatment. We grouped the 23 hospitals based on the number of new patients annually irradiated in 1998; and designated them as group A (> or =900 patients), group B (> or =400 patients and <900 patients), and group C (<400 patients). RESULTS: The median age of the 237 patients was 62 years (range, 25 to 88 years), of which 216 were male and 21 were female. The clinical stages were distributed as follows: for glottis cancer, I; 61.8%, II; 21.5%, III; 4.2%, IVa; 11.1%, IVb; 1.4%, and in supraglottic cancer, I; 4.3%, II; 19.4%, III; 28.0%, IVa; 43.0%, IVb; 5.4%, respectively. Some differences were observed among the 3 groups with respect to the dose calculation method, radiation energy, field arrangement, and use of an immobilization device. No significant difference among 3 hospital groups was observed with respect to treatment modality, irradiation volume, and median total dose delivered to the primary site. CONCLUSION: This study revealed that radiotherapy process and patterns of care are relatively uniform in laryngeal cancer patients in Korean hospitals, and we hope this nationwide data can be used as a basis for the standardization of radiotherapy for the treatment of laryngeal cancer.
Female
;
Glottis
;
Humans
;
Immobilization
;
Korea
;
Laryngeal Neoplasms
;
Male
;
Retrospective Studies
10.Quality of Acute Stroke Care within Emergency Medical Service System in Korea: Proposal for Severe Emergency Medical Center
Kyung Bok LEE ; Ji Sung LEE ; Jeong-Yoon LEE ; Jun Yup KIM ; Han-Yeong JEONG ; Seong-Eun KIM ; Jonguk KIM ; Do Yeon KIM ; Keon-Joo LEE ; Jihoon KANG ; Beom Joon KIM ; Tae Jung KIM ; Sang Joon AN ; Jang-Hyun BAEK ; Seongheon KIM ; Hyun-Wook NAH ; Jong Yun LEE, ; Jee-Hyun KWON ; Seong Hwan AHN ; Keun-Hwa JUNG ; Hee-Kwon PARK ; Tai Hwan PARK ; Jong-Moo PARK ; Yong-Jin CHO ; Im Seok KOH ; Soo Joo LEE ; Jae-Kwan CHA ; Joung-Ho RHA ; Juneyoung LEE ; Boung Chul LEE ; In Ok BAE ; Gui Ok KIM ; Hee-Joon BAE
Journal of the Korean Neurological Association 2023;41(1):18-30
Background:
Korea recently established 70 emergency medical service areas. However, there are many concerns that medical resources for stroke could not be evenly distributed through the country. We aimed to compare the treatment quality and outcomes of acute stroke among the emergency medical service areas.
Methods:
This study analyzed the data of 28,800 patients admitted in 248 hospitals which participated in the 8th acute stroke quality assessment by Health Insurance Review and Assessment Service. Individual hospitals were regrouped into emergency service areas according to the address of the location. Assessment indicators and fatality were compared by the service areas. We defined the appropriate hospital by the performance of intravenous thrombolysis.
Results:
In seven service areas, there were no hospitals which received more than 10 stroke patients for 6 months. In nine service areas, there were no patients who underwent intravenous thrombolysis (IVT). Among 167 designated emergency medical centers, 50 hospitals (29.9%) responded that IVT was impossible 24 hours a day. There are 97 (39.1%) hospitals that meet the definitions of appropriate hospital. In 23 service areas (32.9%) had no appropriate or feasible hospitals. The fatality of service areas with stroke centers were 6.9% within 30 days and 15.6% within 1 year from stroke onset than those without stroke centers (7.7%, 16.9%, respectively).
Conclusions
There was a wide regional gap in the medical resource and the quality of treatments for acute stroke among emergency medical service areas in Korea. The poststroke fatality rate of the service areas which have stroke centers or appropriate hospitals were significantly low.